Bangratz, M., Abdellah, S. A., Berlin, A., Blondeau, C., Guilbot, A., Dubourdeaux, M., & Lemoine, P. (2018). A preliminary assessment of a combination of rhodiola and saffron in the management of mild–moderate depression. Neuropsychiatric disease and treatment,14, 1821Bystritsky, A., Kerwin, L., & Feusner, J. D. (2008). A pilot study of Rhodiola rosea (Rhodax®) for generalized anxiety disorder (GAD). The Journal of Alternative and Complementary Medicine,14(2), 175-180Chatterjee, A., Sen, B., Das, S., & Chatterjee, T. K. (2015). Anti-inflammatory and analgesic activity of methanolic xtract of medicinal plant Rhodiola rosea rhizomes. International Journal of Pharmacolology Resesearch and Review,4(2), 1-8Chen, Q. G., Zeng, Y. S., Qu, Z. Q., Tang, J. Y., Qin, Y. J., Chung, P., ... & Hägg, U. (2009). The effects of Rhodiola rosea extract on 5-HT level, cell proliferation and quantity of neurons at cerebral hippocampus of depressive rats. Phytomedicine,16(9), 830-838Darbinyan, V., Kteyan, A., Panossian, A., Gabrielian, E., Wikman, G., & Wagner, H. (2000). Rhodiola rosea in stress induced fatigue—a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty. Phytomedicine,7(5), 365-371Darbinyan, V., Aslanyan, G., Amroyan, E., Gabrielyan, E., Malmström, C., & Panossian, A. (2007). Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression. Nordic journal of psychiatry,61(5), 343-348Edwards, D., Heufelder, A., & Zimmermann, A. (2012). Therapeutic Effects and Safety of Rhodiola rosea Extract WS® 1375 in Subjects with Life‐stress Symptoms–Results of an Open‐label Study. Phytotherapy Research,26(8), 1220-1225Goyvaerts, B., & Bruhn, S. (2012). Rhodiola rosea-Spezialextrakt SHR-5 bei Burn-out und Erschöpfungssyndrom. Erfahrungsheilkunde,61(02), 79-83Kasper, S., & Dienel, A. (2017). Multicenter, open-label, exploratory clinical trial with Rhodiola rosea extract in patients suffering from burnout symptoms. Neuropsychiatric disease and treatment,13, 889Lee, Y., Jung, J. C., Jang, S., Kim, J., Ali, Z., Khan, I. A., & Oh, S. (2013). Anti-inflammatory and neuroprotective effects of constituents isolated from Rhodiola rosea. Evidence-based complementary and alternative medicine, 2013Lekomtseva, Y., Zhukova, I., & Tartakovsky, I. (2013). Therapy effects and safety of rhodiola rosea extract ws 1375 in subjects with symptoms of chronic fatigue. Бюллетень сибирской медицины,12(5), 73-75Lekomtseva, Y., Zhukova, I., & Wacker, A. (2017). Rhodiola rosea in subjects with prolonged or chronic fatigue symptoms: results of an open-label clinical trial. Complementary medicine research,24(1), 46-52Mao, J. J., Li, Q. S., Soeller, I., Xie, S. X., & Amsterdam, J. D. (2014). Rhodiola rosea therapy for major depressive disorder: A study protocol for a randomized, double-blind, placebo-controlled trial. Journal of clinical trials,4, 170Mao, J. J., Xie, S. X., Zee, J., Soeller, I., Li, Q. S., Rockwell, K., & Amsterdam, J. D. (2015). Rhodiola rosea versus sertraline for major depressive disorder: A randomized placebo-controlled trial. Phytomedicine,22(3), 394-399Mattioli, L., Funari, C., & Perfumi, M. (2009). Effects of Rhodiola rosea L. extract on behavioural and physiological alterations induced by chronic mild stress in female rats. Journal of Psychopharmacology,23(2), 130-142Montiel-Ruiz, R. M., González-Trujano, M. E., & Deciga-Campos, M. (2013). Synergistic interactions between the antinociceptive effect of Rhodiola rosea extract and B vitamins in the mouse formalin test. Phytomedicine,20(14), 1280-1287Olsson, E. M., von Schéele, B., & Panossian, A. G. (2009). A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract shr-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue. Planta medica,75(02), 105-112Palmeri, A., Mammana, L., Tropea, M. R., Gulisano, W., & Puzzo, D. (2016). Salidroside, a bioactive compound of rhodiola rosea, ameliorates memory and emotional behavior in adult mice. Journal of Alzheimer's Disease,52(1), 65-75Perfumi, M., & Mattioli, L. (2007). Adaptogenic and central nervous system effects of single doses of 3% rosavin and 1% salidroside Rhodiola rosea L. extract in mice. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives,21(1), 37-43Shevtsov, V. A., Zholus, B. I., Shervarly, V. I., Vol'Skij, V. B., Korovin, Y. P., Khristich, M. P., ... & Wikman, G. (2003). A randomized trial of two different doses of a SHR-5 Rhodiola rosea extract versus placebo and control of capacity for mental work. Phytomedicine,10(2-3), 95-105Shevtsov, V. A., Zholus, B. I., Shervarly, V. I., Vol'Skij, V. B., Korovin, Y. P., Khristich, M. P., ... & Wikman, G. (2003). A randomized trial of two different doses of a SHR-5 Rhodiola rosea extract versus placebo and control of capacity for mental work. Phytomedicine,10(2-3), 95-105Spasov, A. A., Wikman, G. K., Mandrikov, V. B., Mironova, I. A., & Neumoin, V. V. (2000). A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen. Phytomedicine,7(2), 85-89Ion-George Anghelescu, David Edwards, Erich Seifritz, Siegfried Kasper. (2018). Stress management and the role of Rhodiola rosea: a review. National Library of Medicine.Mark Cropley, Adrian P Banks, Julia Boyle. (2015).The Effects of Rhodiola rosea L. Extract on Anxiety, Stress, Cognition and Other Mood Symptoms. National Library of Medicine.
Afficher plus